Morgan Bron, PharmD, MS

Neurocrine Biosciences, Inc., San Diego, California

  • 2Articles
  • 13.7KReads
  • 2023–2026Active
  • 17Collaborators
  • 12Citations

About

Morgan Bron, PharmD, MS, is affiliated with Neurocrine Biosciences, Inc. in San Diego, California. The author has published on topics including movement disorders, schizophrenia and schizoaffective disorders, and tardive dyskinesia. Bron’s work includes validation of patient-reported outcome measures in valbenazine clinical trials and analyses of real-world benztropine usage patterns in movement disorders. Collaborations frequently include Ashok Parameswaran, Betsy Benning, Christoph U. Correll, Craig Chepke, and Dawn Vanderhoef.

Publications

JCP
Validation for the Tardive Dyskinesia Impact Scale, a Patient-Reported Outcome Measure in Valbenazine Clinical Trials
Narrative Review

Validation for the Tardive Dyskinesia Impact Scale, a Patient-Reported Outcome Measure in Valbenazine Clinical Trials

April 29, 2026

The TDIS followed a similar trajectory to other clinician- and patient-reported outcomes measured in tardive dyskinesia clinical trials, and a change of 4 points in total score is considered...
, , , et al
PCC
Benztropine Usage Patterns in Movement Disorders
Original Research

Benztropine Usage Patterns in Movement Disorders

August 29, 2023

This study evaluated real-world treatment patterns for patients initiating benztropine and examined treatment approaches in patients with drug-induced movement disorders from a health care provider perspective.
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe